These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Human viral diseases: what is next for antiviral drug discovery? De Clercq E Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888 [TBL] [Abstract][Full Text] [Related]
6. RNA interference & inhibition of viruses. Gadkari DA Indian J Med Res; 2005 Mar; 121(3):147-50. PubMed ID: 15802755 [No Abstract] [Full Text] [Related]
7. Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses. Wang X; Zou P; Wu F; Lu L; Jiang S Front Med; 2017 Dec; 11(4):449-461. PubMed ID: 29170916 [TBL] [Abstract][Full Text] [Related]
8. Human- and virus-encoded microRNAs as potential targets of antiviral therapy. Kurzyńska-Kokorniak A; Jackowiak P; Figlerowicz M; Figlerowicz M Mini Rev Med Chem; 2009 Jul; 9(8):927-37. PubMed ID: 19601888 [TBL] [Abstract][Full Text] [Related]
9. Staying ahead of viruses: a never ending task. Lamarre D; Wainberg MA Curr Opin Virol; 2012 Oct; 2(5):569-71. PubMed ID: 23025913 [No Abstract] [Full Text] [Related]
10. Broad-Spectrum Antivirals and Antiviral Drug Combinations. Oksenych V; Kainov DE Viruses; 2022 Feb; 14(2):. PubMed ID: 35215894 [TBL] [Abstract][Full Text] [Related]
11. [Molecular genetic aspects of interferon induction and antiviral action]. Bazhan SI; Belova OE Vestn Ross Akad Med Nauk; 1998; (3):18-24. PubMed ID: 9608271 [TBL] [Abstract][Full Text] [Related]
12. Nucleic acid-based drugs against emerging zoonotic viruses. Wong JP Future Med Chem; 2015; 7(13):1709-19. PubMed ID: 26399689 [TBL] [Abstract][Full Text] [Related]
13. New horizons for antiviral drug discovery from virus-host protein interaction networks. de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912 [TBL] [Abstract][Full Text] [Related]
14. Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs. Naesens L; Zoulim F Curr Opin Virol; 2017 Jun; 24():v-vii. PubMed ID: 28743435 [No Abstract] [Full Text] [Related]
15. Application of modified antisense oligonucleotides and siRNAs as antiviral drugs. Wagner A; Bock CT; Fechner H; Kurreck J Future Med Chem; 2015; 7(13):1637-42. PubMed ID: 26381598 [No Abstract] [Full Text] [Related]
16. Therapeutic Potential of Spirooxindoles as Antiviral Agents. Ye N; Chen H; Wold EA; Shi PY; Zhou J ACS Infect Dis; 2016 Jun; 2(6):382-92. PubMed ID: 27627626 [TBL] [Abstract][Full Text] [Related]
17. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. Randall RE; Goodbourn S J Gen Virol; 2008 Jan; 89(Pt 1):1-47. PubMed ID: 18089727 [TBL] [Abstract][Full Text] [Related]
18. Abstracts of the 19th International Conference on Antiviral Research (ICAR), San Juan, Puerto Rico, May 7-11, 2006. Antiviral Res; 2006 May; 70(1):A26-89. PubMed ID: 16696114 [No Abstract] [Full Text] [Related]
19. Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems. Trevisan M; Sinigaglia A; Desole G; Berto A; Pacenti M; Palù G; Barzon L Viruses; 2015 Jul; 7(7):3835-56. PubMed ID: 26184286 [TBL] [Abstract][Full Text] [Related]
20. [Status and prospects of the chemotherapy of viral infections]. Pershin GN Farmakol Toksikol; 1975; 38(5):517-27. PubMed ID: 1183580 [No Abstract] [Full Text] [Related] [Next] [New Search]